Search results
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
FierceBiotech· 2 hours agoVir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 7 hours agoVirion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress PR Newswire PHILADELPHIA, June 5, 2024 Highlights from the Data
Aligos Therapeutics Presents Positive Data at the EASL Congress 2024 - Aligos Therapeutics...
Benzinga· 8 hours agoSOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos")), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet
Health advocates and medical professionals seek elimination of Ohio laws targeting HIV patients
News Channel 5 Cleveland· 3 hours agoThe following article was originally published in the Ohio Capital Journal and published on...
LGBTQ+ population faces greater cancer risks. Also faces barriers to care, studies show.
USA TODAY via Yahoo News· 2 days agoCorrection: This story was updated to reflect that hepatitis B vaccinations were higher among LGBTQ+ people than heterosexual adults. LGBTQ+ people are ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 8 hours agoOcean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research scientists, today congratulates its JV partner Virion ...
Arbutus' Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity...
Benzinga· 8 hours agoAt the end of treatment, 33.3% of patients receiving imdusiran for 48 weeks, interferon (IFN) for 24 weeks and ongoing nucleoside analogue (NA) therapy achieved undetectable levels of HBsAg that were maintained in 100%
Get regular blood tests and screening if you have multiple sex partners
Rolling Out· 3 days agoIf you have regular sex partners, getting regular STD testing is an essential part of maintaining...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 3 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic
Top 10 most common cancers among Blacks
Rolling Out· 7 days agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
